Related Experiment Video
Updated: Mar 26, 2026

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production
Published on: October 6, 2023
Adverse Cardiovascular Events after a Venomous Snakebite in Korea
Oh Hyun Kim1, Joon Woo Lee1, Hyung Il Kim1
1Department of Emergency Medicine, Wonju College of Medicine, Yonsei University, Wonju, Korea.
Insights
Adverse cardiovascular events (ACVEs) affect 13.8% of venomous snakebite patients in Korea, often involving myocardial injury. Those with ACVEs had more pre-existing heart conditions and bleeding complications.
Area of Science:
- Cardiology
- Toxicology
- Emergency Medicine
Background:
- Cardiac involvement is an under-recognized complication of venomous snakebites.
- Limited data exists on adverse cardiovascular events (ACVEs) from snakebites in Korea.
Purpose of the Study:
- To determine the prevalence of ACVEs in Korean venomous snakebite patients.
- To compare clinical features between patients with and without ACVEs.
Main Methods:
- Retrospective review of 65 venomous snakebite cases (May 2011-Oct 2014).
- ACVEs defined as myocardial injury, shock, ventricular dysrhythmia, or cardiac arrest.
- Analysis of patient demographics, clinical features, and outcomes.
Main Results:
- ACVEs occurred in 13.8% of patients (9/65).
- Myocardial injury (13.8%) and shock (3.1%) were observed; no ventricular dysrhythmia or cardiac arrest.
- Patients with ACVEs had higher rates of underlying cardiac disease (p=0.017) and bleeding complications (p=0.031).
Conclusions:
- A significant proportion of venomous snakebite patients experience ACVEs.
- Underlying cardiac disease and bleeding complications are more common in patients with ACVEs.
Purpose:
Although cardiac involvement is an infrequently recognized manifestation of venomous snakebites, little is known of the adverse cardiovascular events (ACVEs) arising as a result of snakebite in Korea. Accordingly, we studied the prevalence of ACVEs associated with venomous snakebites in Korea and compared the clinical features of patients with and without ACVEs.
Materials And Methods:
A retrospective review was conducted on 65 consecutive venomous snakebite cases diagnosed and treated at the emergency department of Wonju Severance Christian Hospital between May 2011 and October 2014. ACVEs were defined as the occurrence of at least one of the following: 1) myocardial injury, 2) shock, 3) ventricular dysrhythmia, or 4) cardiac arrest.
Results:
Nine (13.8%) of the 65 patients had ACVEs; myocardial injury (9 patients, 13.8%) included high sensitivity troponin I (hs-TnI) elevation (7 patients, 10.8%) or electrocardiogram (ECG) determined ischemic change (2 patients, 3.1%), and shock (2 patient, 3.1%). Neither ventricular dysrhythmia nor cardiac arrest was observed. The median of elevated hs-TnI levels observed in the present study were 0.063 ng/mL (maximum: 3.000 ng/mL) and there was no mortality in the ACVEs group. Underlying cardiac diseases were more common in the ACVEs group than in the non-ACVEs group (p=0.017). Regarding complications during hospitalization, 3 patients (5.4%) in the non-ACVEs group and 3 patients (33.3%) in the ACVEs group developed bleeding (p=0.031).
Conclusion:
Significant proportion of the patients with venomous snakebite is associated with occurrence of ACVEs. Patients with ACVEs had more underlying cardiac disease and bleeding complication.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

